Nutritional supplementation in cases of canine cognitive dysfunction-A clinical trial

Applied Animal Behaviour Science

Volumn 105, Issue 4, 2007, Pages 284-296

  Heath, Sarah Elizabeth ^a   Barabas, Stephen ^b   Craze, Paul Graham ^c  

^a Behavioural Referrals Veterinary Practice   (United Kingdom)

^b VetPlus Ltd   (United Kingdom)

^c UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

Alzheimer's disease; Canine; Cognitive; Dementia; Disorientation; Nutraceutical

Indexed keywords

BEHAVIOR; CANID; COGNITION; NUTRITIONAL STATUS;

EURASIA; EUROPE; UNITED KINGDOM; WESTERN EUROPE;

CANIS FAMILIARIS;

EID: 34249331341     PISSN: 01681591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.applanim.2006.11.008     Document Type: Article

References (35)

1. Bain M.J., Hart B.L., Cliff K.D., and Ruehl W.W. Predicting behavioural changes associated with age-related cognitive impairment in dogs. J. Am. Vet. Med. Assoc. 218 (2001) 1792-1795
2. Bland J.M., and Altman D.G. Cronbach's alpha. Brit. Med. J. 314 (1997) 572
3. Borras D., Ferrer I., and Pumarola M. Age related changes in the brain of the dog. Vet. Pathol. 36 (1999) 202-211
4. Cenacchi B., Bertoldin T., Farina C., Fiori M.G., and Crepaldi G. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging (Clin. Exp. Res.) 5 (1993) 123-133
5. Cummings B.J., Head E., Afagh A.J., Milgram N.W., and Cotman C.W. The canine as an animal model of human ageing and dementia. Neurobiol. Ageing 17 (1996) 259-268
6. Hagen T.M., Liu J., and Lykkesfeldt J. Feeding acetyl-l-carnitine and alpha lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc. Natl. Acad. Sci. 99 (2002) 1870-1875
7. Heath S.E. Behaviour problems in the geriatric pet. In: Horwitz D., Mills D., and Heath S. (Eds). BSAVA Manual of Canine and Feline Behavioural Medicine (2002), BSAVA, Cheltenham, UK 109-118
8. Hills. U.S. Marketing Research Summary, Omnibus Study on Aging Pets (2000), Hill's Pet Nutrition Inc.
9. Horrocks L.A., and Yeo Y.K. Health benefits of docosahexaenoic acid. Pharmacol. Res. 40 (1999) 211-215
10. Joseph J.A., Denisova N.A., Bielinski D., Fisher D.R., and Shukitt-Hale B. Oxidative stress protection and vulnerability in aging: putative nutritional implications for intervention. Mech. Ageing Dev. 116 (2000) 141-153
11. Kontush A., and Schekatolina S. Vitamin E in neurodegenerative disorders: Alzheimer's disease. Ann. N.Y. Acad. Sci. 1031 (2004) 249-262
12. Kyle D.J., Schaefer E., Patton G., and Beiser A. Low serum docosahexaenoic acid is a significant risk factor for Alzheimer's dementia. Lipids 34 Suppl. (1999) S245
13. Landsberg G., and Araujo J.A. Behaviour problems in geriatric pets. Vet. Clin. North Am. Small Anim. Pract. 35 (2005) 675-698
14. Landsberg G., Hunthausen W., and Ackerman L. Handbook of Behaviour Problems of the Dog and Cat. 2nd ed. (2003), Saunders, Elsevier Saunders, Oxford. England pp. 269-304
15. Liu J., Killilea D.W., and Ames B.N. Age related mitochondrial oxidative decay, improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-l-carnitine and/or R-alpha lipoic acid. Proc. Natl. Acad. Sci. 99 (2002) 1876-1881
16. Liu J., Head E., Gharib A.M., Yuan W., Ingersoll R.T., Hagen T.M., Cotman C.W., and Ames B.N. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-l-carnitine and/or R-alpha lipoic acid. Proc. Natl. Acad. Sci. 99 (2002) 2356-2361
17. Lookwood K., Moesgaard S., Hanioka T., and Folkers K. Apparent partial remission of breast cancer in "high risk" patients supplemented with nutritional antioxidants, essential fatty acids and co-enzyme Q10. Mol. Aspects Med. 15 Suppl. (1994) s231-s240
18. Lookwood K., Moesgaard S., and Folkers K. Partial and complete regression of breast cancer in patients in relation to dosage of co-enzyme Q10. Biochem. Biophys. Res. Commun. 119 (1994) 1504-1508
19. Lucas A., Morley R., Cole T.J., Lister G., and Leeson-Payne C. Breast milk and subsequent intelligence quotient in children born pre-term. Lancet 1 339 (1992) 261-264
20. Maggioni M., Picotti G.B., Bondiolotti G.P., Panerai A., Cenacchi T., Nobile P., and Bambilla F. Effects of phosphatidylserine therapy in geriatric patients with depressive disorders. Acta Psychiatr. Scand. 81 (1990) 265-270
21. Milgram N.W., Head E., Cotman C.W., Muggenberg B., and Zicker S.C. Age dependent cognitive dysfunction in canines: dietary intervention. In: Overall K.L., Mills D.S., Heath S.E., and Horwitz D. (Eds). Proceedings of the 3rd International Congress on Veterinary Behavioural Medicine UFAW. Wheathampstead, UK (2001) 53-57
22. Milgram N.W., Head E., Muggenburg B., Holowachuk D., Murphey H., Estrada J., Ikeda-Douglas C.J., Zicker S.C., and Cotman C.W. Landmark discrimination learning in the dog; effects of age, an antioxidant fortified food and cognitive strategy. Neurosci. Biobehav. Rev. 26 (2002) 679-695
23. Milgram N.W., Zicker S.C., Head E., Muggenburg B.A., Murphey H., Ikeda-Douglas C.J., and Cotman C.W. Dietary enrichment counteracts age-associated cognitive dysfunction in canines. Neurobiol. Aging 23 (2002) 737-745
24. Milgram N.W., Head E., Zicker S.C., Ikeda-Douglas C., Murphey H., Muggenberg B.A., Siwak C.T., Tapp P.D., Lowry S.R., and Cotman C.W. Long-term treatment with antioxidants and a program of behavioural enrichment reduces age-dependent impairment in discrimination and reversal learning in beagle dogs. Exp. Gerontol. 39 (2004) 753-765
25. Neilson J.C., Hart B.L., Cliff K.D., and Ruehl W.W. Prevalence of behavioural changes associated with age-related cognitive impairment in dogs. J. Am. Vet. Med. Assoc. 18 (2001) 1787-1791
26. Otsuka M. Analysis of dietary factors in Alzheimer's disease: clinical use of nutritional intervention for prevention and treatment of dementia. Jpn. J. Geriatr. 37 (2000) 970-973
27. Pocernich C.B., La Fontaine M., and Butterfield D.A. In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain. Neurochem. Int. 36 (2000) 185-191
28. Prasad K.N., Hovland A.R., Cole W.C., Prasad K.C., Nahreini P., Edwards-Prasad J., and Andreatta C.P. Multiple antioxidants in the prevention and treatment of Alzheimer disease: analysis of biologic rationale. Clin. Neuropharmacol. 23 (2000) 2-13
29. Samson J.C. The biological basis of phosphatidylserine pharmacology. Clin. Trials J. 24 (1987) 1-8
30. Sastre J., Pallardo F.V., and Vina J. Mitochondrial oxidative stress plays a key role in aging and apoptosis. IUBMB Life 49 (2000) 427-435
31. Studzinski C.M., Christie L.A., Araujo J.A., Burnham W.M., Head E., Cotman C.W., and Milgram N.W. Visuospatial function in the beagle dog: an early marker of cognitive decline in a model of human cognitive aging and dementia. Neurobiol. Learn. Mem. 86 (2006) 197-204
32. Suzuki S., Yamatoya H., Sakai M., Kataoka A., Furushiro M., and Kudo S. Oral administration of soybean lecithin transphosphatidylate phosphatidylserine improves memory impairment in aged rats. J. Nutr. 131 (2001) 2951-2956
33. Vannuchi M.G., Casamenti F., and Pepeu G. Decrease of acetylcholine release from cortical slices in aged rats: investigations into its reversal by phosphotidylserine. J. Neurochem. 55 (1990) 819-825
34. Youdim K.A., Martin A., and Joseph J.A. Essential fatty acids and the brain: possible health implications. Int. J. Dev. Neurosci. 18 (2000) 383-399
35. Zandi P.P., Anthony J.C., Khachaturian A.S., Stone S.V., Gustafson D., Tschanz J.T., Norton M.C., Welsh-Bohmer K.A., Breitner J.C.S., and for the Cache County Study Group. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements the Cache County Study. Arch. Neurol. 61 (2004) 82-88